Expose hidden spreads, compare real acquisition costs, and get expert guidance. The only PBM intelligence platform with a dedicated AI expert.
From drug pricing to contract analysis—built for benefits professionals.
Compare NADAC acquisition costs vs typical PBM pricing with spread analysis.
Market share, ownership, transparency ratings for major PBMs.
AI-powered detection of problematic clauses and hidden fee structures.
Model potential savings from pass-through pricing and rebate improvements.
150+ vetted questions across 8 categories with PDF export.
Reference guide to contract provisions that reduce transparency.
Compare NADAC acquisition costs against typical PBM pricing. See exactly where spread pricing inflates your costs.
Market share, ownership structures, and transparency assessments for major PBMs.
Paste contract text to scan for problematic clauses, hidden fees, and unfavorable terms.
Estimate annual savings from pass-through pricing and rebate improvements.
150+ vetted questions to surface pricing opacity and evaluate PBM proposals.
Reference library of clauses associated with pricing opacity and unfavorable terms.
RxPBM.ai provides information for educational purposes only. This platform does not constitute legal, financial, or professional advice.
Drug pricing uses NADAC data from CMS. Spread estimates are based on FTC findings. Actual pricing varies significantly by contract. Always verify with actual quotes and consult qualified professionals.
Weekly intelligence on pricing trends and regulatory changes.
By subscribing, you agree to receive emails from RxPBM.ai. Unsubscribe anytime.